1. Gore RM, Levine MS. Textbook of gastrointestinal radiology. 2008. 3rd ed. Philadelphia: Saunders;628–649.
2. Kim SY, Kim KW, Kim AY, Ha HK, Kim JS, Park SH, et al. Bloodborne metastatic tumors to the gastrointestinal tract: CT findings with clinicopathologic correlation. AJR Am J Roentgenol. 2006. 186:1618–1626.
3. Menuck LS, Amberg JR. Metastatic disease involving the stomach. Am J Dig Dis. 1975. 20:903–913.
4. Wallmeroth A, Wagner U, Moch H, Gasser TC, Sauter G, Mihatsch MJ. Patterns of metastasis in muscle-invasive bladder cancer (pT2-4): an autopsy study on 367 patients. Urol Int. 1999. 62:69–75.
5. Pak K, Ishida A, Arai Y, Tomoyoshi T. An autopsy case of untreated bladder cancer. Hinyokika Kiyo. 1987. 33:1261–1265.
6. Kanne JP, Mankoff DA, Baird GS, Minoshima S, Livingston RB. Gastric linitis plastica from metastatic breast carcinoma: FDG and FES PET appearances. AJR Am J Roentgenol. 2007. 188:W503–W505.
7. Levine MS, Kong V, Rubesin SE, Laufer I, Herlinger H. Schirrous carcinoma of the stomach: radiologic and endoscopic diagnosis. Radiology. 1990. 175:151–154.
8. Ha HK, Jee KR, Yu E, Yu CS, Rha SE, Lee IJ, et al. CT features of metastatic linitis plastica to the rectum in patients with peritoneal carcinomatosis. AJR Am J Roentgenol. 2000. 174:463–466.
9. Gollub MJ, Schwartz MB, Shia J. Scirrhous metastases to the gastrointestinal tract at CT: the malignant target sign. AJR Am J Roentgenol. 2009. 192:936–940.
10. Kunju LP, Mehra R, Snyder M, Shah RB. Prostate-specific antigen, high-molecular-weight cytokeratin (clone 34betaE12), and/or p63: an optimal immunohistochemical panel to distinguish poorly differentiated prostate adenocarcinoma from urothelial carcinoma. Am J Clin Pathol. 2006. 125:675–681.